Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Liabilities and Shareholders Equity (2021 - 2026)

Abpro Holdings' (ABPO) quarterly Liabilities and Shareholders Equity came in at $6.9 million in Q1 2026, up 145.44% YoY from $2.8 million in Q1 2025, and up 545.81% on a QoQ basis from $1.1 million in Q4 2025.

Abpro Holdings (ABPO) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Abpro Holdings (ABPO) has 6 years of Liabilities and Shareholders Equity data on file, last reported at $6.9 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity rose 145.44% year-over-year to $6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.1 million (down 43.5% YoY) and the FY2025 annual result came in at $1.1 million, down 77.19% from the prior year.
  • Liabilities and Shareholders Equity climbed to $6.9 million in Q1 2026, from $1.1 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $313.6 million in Q1 2023 to a low of $1.1 million in Q4 2025.
  • A 5-year average of $98.2 million and a median of $7.9 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity soared 85839.33% — and 2023, when it tumbled 98.92%.
  • Tracing ABPO's Liabilities and Shareholders Equity over 5 years: stood at $310.6 million in 2022, then plunged by 98.92% to $3.4 million in 2023, then jumped by 38.93% to $4.7 million in 2024, then slumped by 77.19% to $1.1 million in 2025, then soared by 545.81% to $6.9 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $6.9 million (Q1 2026), $1.1 million (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 10.03 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 10.96 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 9.18 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 5.56 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 25.60 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 2.10 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 19.82 Bn
10 Abpro Holdings 1.14 Mn 1.14 Mn - 5.24 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.87 Mn
Dec 31, 2025 1.06 Mn
Sep 30, 2025 1.70 Mn
Jun 30, 2025 3.48 Mn
Mar 31, 2025 2.80 Mn
Dec 31, 2024 4.66 Mn
Sep 30, 2024 7.86 Mn
Jun 30, 2024 7.90 Mn
Mar 31, 2024 7.53 Mn
Dec 31, 2023 3.36 Mn
Sep 30, 2023 37.52 Mn
Jun 30, 2023 38.44 Mn
Mar 31, 2023 313.65 Mn
Dec 31, 2022 310.56 Mn
Sep 30, 2022 308.23 Mn
Jun 30, 2022 306.98 Mn
Mar 31, 2022 306.90 Mn
Dec 31, 2021 361,372.00